Filing Details
- Accession Number:
- 0001493152-22-019731
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2022-07-18 17:09:00
- Reporting Period:
- 2022-07-14
- Accepted Time:
- 2022-07-18 17:09:00
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1873835 | Immix Biopharma Inc. | IMMX | Pharmaceutical Preparations (2834) | 454869378 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1904837 | Sean Senn | C/O Immix Biopharma, Inc. 11400 West Olympic Blvd., Suite 200 Los Angeles CA 90064 | No | No | Yes | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Disposition | 2022-07-14 | 200 | $2.75 | 899,800 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | S | Direct |
Billionaire Hedge Funds
